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Methemoglobinemia, one of the rare causes of cyanosis and hypoxemia, may occur in congenital and
acquired forms. Coexistence of cyanosis and hypoxemia suggests an etiology associated with an
underlying cardiac disease ﬁrstly, but if any cardiac pathology exists pulmonary diseases are investigated
generally. Considering bronchial asthma in a young patient with shortness of breath is usual. On the
other hand, evaluating all the signs and symptoms together with laboratory results is important in
diagnosis of rare diseases such as methemoglobinemia. In this paper we present a congenital methe-
moglobinemia case who was treated with bronchodilator therapy for a period of nearly ﬁve years
because of misdiagnosis of asthma.
Crown Copyright  2012 Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Methemoglobinemia, a disorder characterized by the presence
of high methemoglobin levels in the blood, can occur in congenital
and acquired forms. Methemoglobin is an oxidized form of hemo-
globin, which has an increased afﬁnity of oxygen and reduced
ability to release oxygen to tissues. The oxygenehemoglobin
dissociation curve is therefore shifted to the left. When methe-
moglobin concentration is elevated in red blood cells, tissue
hypoxia may occur. This disorder may present with several symp-
toms such as cyanosis, dyspnea, headache. Because it is a rare cause
of cyanosis and hypoxemia, the diagnosis of methemoglobinemia is
oftenly delayed. Another reason of delayed diagnosis is that unless
methemoglobin levels above 40%, the disease often remains
asymptomatic. The true diagnosis and treatment of methemoglo-
binemia reduces mortality. In this paper we present a congenital
methemoglobinemia case who was treated with bronchodilator
therapy for a period of nearly ﬁve years because of misdiagnosis of
asthma.2. Case report
20-year-old male patient was admitted to our outpatient clinic
of chest diseases with complaints of chest pain, exertional dyspnea
and cyanosis. The patient stated that the complaints are present forvruz@gata.edu.tr (O. Nevruz),
u.tr (H. Bilgic).
evier Ltd. Open access under CC BY-NC4e5 years and using inhaled bronchodilator therapy with a diag-
nosis of asthma. In physical examination, vital signs of the patient
were normal. Cyanosis is present on the hands and lips, and SpO2
value was measured as 88e90% in room air. PaO2 was measured as
54 mmHg in arterial blood gas analysis. Upon this we performed
chest radiography and pulmonary artery computerized tomog-
raphy angiography with a prior diagnosis of pulmonary embolism
(acute or chronic), but no pulmonary radiologic lesion was found.
Subsequently, ecocardiographywas performed for investigating the
etiology of hypoxemia but any pathology was not found again.
Although patients treated with nasal oxygen with a FiO2 value of
35%, SpO2% measurements were about 89e90%. Whenwe received
a more detailed history from patient it was learned that his big
brother also had similar complaints and he had died for this reason.
Thereupon, considering the etiology of hypoxemia in this patient
may be related with a congenital hematological disease serum
methemoglobin level was measured. Serum methemoglobin level
of the patient was 40 times higher than normal range. No history of
drug use or environmental exposure which may be related with
this laboratory disorder was detected. Taking into account the
familial history of the patient and no drug use story, the etiology
of the methemoglobinemia was evaluated as congenital. The
congenital etiology of methemoglobinemia could not be deter-
mined due to lack of laboratory facilities. Before starting treatment
we investigated Glucose-6-phosphate dehydrogenase deﬁciency
(G6PD) deﬁciency and found that the patient does not have G6PD.
Upon this, the patient was treated with methylene blue and the
methemoglobin levels decreased to 8e9%. Finally, the oxygen
saturation value of the patient on room air rose to 94e96% and he
was discharged.-ND license.
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Red blood cells contain 4 hemoglobin chains which are
composed of 4 polypeptide chains associated with 4 heme groups.
These heme groups contain iron molecules in the reduced or
ferrous form (Fe2þ). Ferrous form iron can combine with oxygen by
sharing an electron, to form oxyhemoglobin. By releasing the
oxygen to the tissues, the iron molecule is restored to its original
ferrous state. Hemoglobin can accept and transport oxygen only
with the ferrous form iron atom. When hemoglobin becomes
oxidized and loses an electron, it is converted to the ferric state
(Fe3þ) which is called methemoglobin. Because methemoglobin
lacks the electron that is needed to form a bond with oxygen, it is
incapable of oxygen transport. In methemoglobinemia the oxygen
delivery to tissues is impaired and also the oxygen hemoglobin
dissociation curve shifts to the left.1,2 Generally, methemoglobi-
nemia is accepted as an acquired disorder; however, a very small
number of congenital cases are also reported in the literature.3,4
Because of the reduced oxygen-carrying capacity of methemo-
globin, cyanosis which is unresponsive to oxygen therapy and
sometimes fetal tissue hypoxia in severe cases may be seen in
methemoglobinemia. When methemoglobin levels are relatively
low especially in congenital methemoglobinemia, cyanosis may be
observed without cardiopulmonary symptoms and patient may be
observed in a relaxed appearance despite the existence of cyanosis.
Cyanosis usually occurs from birth in these patients. Cyanosis does
not respond to oxygen therapy and its level depends on the amount
of methemoglobin.1,2 Methemoglobin levels may be 15e30% in
untreated patients. It can be resulted with CNS depression in about
20e45%, arrhythmias, shock and coma in 45e55%, death in over
70% of the patients. Methemoglobin level is lower in patients with
anemia but this situation may cause hypoxic symptoms. Erythro-
cyte life is normal and light compensatory eritrocitosis may be seen
in these patients. Before using methylene blue in the diagnosis and
the treatment of patient, clinician must be sure that the patient
does not have glucose-6-phosphate dehydrogenase (G6PD) deﬁ-
ciency. It should be noted that using oxidants such as methylene
blue in patients with G6PD deﬁciency may cause severe hemolytic
crisis.5,6 There are two forms of methemoglobinemia, congenital
and acquired forms. Diaphorase-I deﬁciency, hemoglobin variants
(Hgb H, Hgb M) and G6PD deﬁciency are major causes of congenital
form.1 Environmental exposure and toxins are acquired causes of
the disorder. Nitrates, chlorates, aniline are agents which may lead
to methemoglobinemia.7
In a retrospective study 138 cases of acquired methemoglobi-
nemia were examined and etiologic agents were found to be
dapsone in 42%, benzocaine in 4%, primaquine in 4% of the patients.
A known side effect of dapsone therapy is methemoglobinemia
during its usage in autoimmune diseases and prophylaxis against
Pneumocystis pneumonia (PCP) caused by Pneumocystis jirovecii.
In another study performed on 242 cases of methemoglobinemia
related with anesthesia and benzocaine found to be responsible in
60% of the cases.8
In our case there was no history of drug use or environmental
exposure, and the most signiﬁcant complaint was shortness of
breath induced by exercise. Considering that the patient’s brother
also died with similar complaints at the age of ﬁfteen, strength-
ening the idea that methemoglobinemia is congenital in thispatient. The diagnosis and treatment of bronchial asthma by
previous physicians, may be explained with insufﬁcient investiga-
tion of the complaints, ﬁndings and history.
After exposure to fenasetin and sulfanamid a rare disorder,
sulfhemoglobinemia, may occur which can be clinically confused
with methemoglobinemia. The distinction can be made by non-
responsiveness of sulfhemoglobinemia to treatment with methy-
lene blue. Additionally, the deﬁnitive diagnosis can be made by
spectrometric examination.9
Administration of 1e2 mg/kg IV methylene blue and oral
vitamin C have great help for the treatment of methemoglobi-
nemia. N-acetylcysteine, cimetidine and ketokanazol are experi-
mental but promising treatments in methemoglobinemia yet.
Exchange transfusion is an alternative treatment in patients who
are refractory to methylene blue.10
Wemet a similar methemoglobinemia case in the literaturewho
was treated as asthma previously. Because cyanosis and shortness
of breath complaints were constant despite the asthma therapy, the
patient was detected and homozygous type 1b5r deﬁciency was
found in the patient. The authors stated that the patient was freed
from unnecessary treatment and the use of unnecessary drugs.11
Existence of dyspnea, hypoxemia and cyanosis in a patient ﬁrstly
signs heart diseases (atrial septal defect, ventricular septal defect,
etc.) and lung diseases (pulmonary embolism, etc.). Therefore
evaluation of these diseases is a normal procedure. On the other
hand considering methemoglobinemia may be life-saving before
making a bronchial asthma diagnosis in such young patients in
whom the reason for these ﬁndings remains un-explained.
As a result, in young adult patients receiving bronchodilator
therapy with diagnosis of bronchitis, methemoglobinemia should
be considered as the reason of cyanosis and hypoxemia.Conﬂict of interest statement
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